Visit other SMART + STRONG sites:
POZREAL HEALTHTU SALUD
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Life Expectancy With HIV Increases Dramatically
HIV Eradication: One Step Closer
Scientists Crack Integrase Inhibitor Mystery
Gilead Reports Success With Quad Pill and Boosting Drug
New Hope for HIV Eradication
Study: Demand for HIV Vaccine Will Depend on How Good It Is
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailrssprint

December 8, 2008

HIV-Positive Women More Likely to Have Precancerous Anal Lesions

HIV-positive women were more than twice as likely to have precancerous anal lesions as their HIV-negative counterparts, according to a study published in the January 2 issue of AIDS.

Recent studies have suggested that anal cancer may be more common in people with HIV. As with cervical cancer, infection with the human papillomavirus (HPV) is believed to be the primary driver behind the development of anal cancer. A number of studies have compared the rates of cervical cancer and precancerous cervical lesions between HIV-positive and HIV-negative women, and have found an increased risk for HIV-positive women. Few studies, however, have explored the comparative risk for precancerous anal lesions—called anal intraepithelial neoplasias (AIN)—in HIV-positive women.

To examine the rates of precancerous anal lesions in women, Nancy Hessol, MSPH, from the University of California in San Francisco, and her colleagues from the Women’s Interagency HIV Study (WIHS) examined 470 HIV-positive and 185 HIV-negative women, most between 31 and 50 years of age.

Just over half were smokers and just under 50 percent had ever engaged in anal sex—both being risk factors for anal lesions. It is important to note, however, that women who’ve never engaged in anal sex can get anal lesions and anal cancer, especially if they’ve had HPV infection of the vagina or cervix.

Hessol’s team found significant differences between the HIV-positive and HIV-negative women. Eighty percent of the HIV-positive women had evidence of anal HPV infection, compared with 50 percent of HIV-negative women. They also reported that HIV-positive women were 40 percent more likely to have low-grade AIN and three times as likely to have high-grade AIN as HIV-negative women. Overall, 16 percent of HIV-positive women had either low- or high-grade AIN.

Contrary to some studies of cervical cancer, a woman’s smoking history did not appear to influence the development of AIN. The factor most strongly associated with high-grade AIN was infection with strains of HPV that are associated with cancer. The factor associated with low-grade AIN was infection with any strain of HPV, both those linked to cancer and those that are not. Though the authors do not make recommendations about screening for anal lesions—such as anal Pap smears and anoscopy—HIV-positive women may wish to discuss this study and these procedures with their health care providers.

Search: human papillomavirus, HPV, anal intraepithelial neoplasia (AIN), anal cancer, cervical cancer, Nancy Hessol, UCSF


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

       


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
My Cool Tools
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine
Conference Coverage

17th Conference on Retroviruses and Opportunistic Infections (CROI 2010)
San Francisco, CA
February 16-19, 2010


5th IAS Conference on HIV Pathogenesis Treatment and Prevention (IAS 2009)
Cape Town, South Africa
July 19-22, 2009


16th Conference on Retroviruses and Opportunistic Infections (CROI 2009)
Montréal, Canada
February 8-11, 2009

more conference coverage


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2010 Smart + Strong. All Rights Reserved. Terms of use and Your privacy